Skip to content
OpenCapital
Get started

Spruce Biosciences, Inc. SPRB Q4 2024 earnings

Reported April 2, 2025 · Before market open

Revenue$697.0KMiss by $188.0KDiluted EPS-$0.23Beat by $0.01
Revenue estimate$885.0K
EPS estimate-$0.24

Next report

Aug 13, 2026 (in a month)
EPS estimate-$6.04

Versus estimates

Revenue

Q4 2024$697.0KMiss by $188.0K

Diluted EPS

Q1 2026-$8.94Miss by $1.62Q4 2025-$9.58Beat by $3.29Q3 2025-$14.58Beat by $0.98Q2 2025-$3.50Beat by $14.55Q1 2025-$24.06Miss by $5.26
Q4 2024-$0.23Beat by $0.01

Ask the moment Spruce Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Spruce Biosciences, Inc. report Q4 2024 earnings?
Spruce Biosciences, Inc. (SPRB) reported Q4 2024 earnings on April 2, 2025 before market open.
What were Spruce Biosciences, Inc. 's Q4 2024 revenue and EPS?
Spruce Biosciences, Inc. reported revenue of $697.0K and diluted EPS of $-0.23 for Q4 2024.
Did Spruce Biosciences, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $885.0K by $188.0K. EPS beat the consensus estimate of $-0.24 by $0.01.